14523-53-6 Usage
General Description
Spiro[4.5]dec-6-en-8-one, also known as decalone, is a bicyclic ketone compound with a spiro[4.5]decane skeleton. It is a colorless liquid with a sweet smell and is used as a flavoring agent in the food industry. Decalone is also used in the manufacture of perfumes and as a chemical intermediate in the production of other organic compounds. It has been identified as a potential component in the essential oils of various plant species and has been studied for its potential medicinal and biological properties, including its antibacterial and antifungal activities. Overall, spiro[4.5]dec-6-en-8-one has a variety of practical applications in industry and potential uses in scientific research.
Check Digit Verification of cas no
The CAS Registry Mumber 14523-53-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,4,5,2 and 3 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 14523-53:
(7*1)+(6*4)+(5*5)+(4*2)+(3*3)+(2*5)+(1*3)=86
86 % 10 = 6
So 14523-53-6 is a valid CAS Registry Number.
InChI:InChI=1/C10H14O/c11-9-3-7-10(8-4-9)5-1-2-6-10/h3,7H,1-2,4-6,8H2
14523-53-6Relevant articles and documents
Julia,Malassine
, p. 987 (1971)
CARBOXAMIDE DERIVATIVES
-
Paragraph 0451-0452, (2015/12/17)
The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
Inhibitors Of The Influenza A Virus M2 Proton Channel
-
Page/Page column 8-9, (2012/02/06)
Provided are compounds that are capable of modulating the activity of the influenza A virus via interaction with the M2 transmembrane protein. Also provided are methods for treating an influenza A-affected disease state or infection comprising administering a composition comprising one or more compounds that have been identified as being capable of interaction with the M2 protein.